Erratum: XBP 1-Deficiency Abrogates Neointimal Lesion of Injured Vessels Via Cross Talk with the PDGF Signaling (Arterioscler Thromb Vasc Biol. (2015) 35 (2134-2144) DOI: 10.1161/ATVBAHA.115.305420);XBP 1-deficiency abrogates neointimal lesion of injured vessels via cross talk with the PDGF signaling

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 10, 2015, Pages 2134-2144

  Zeng, Lingfang ^a   Li, Yi ^a   Yang, Juanyao ^a,b   Wang, Gang ^c   Margariti, Andriana ^d   Xiao, Qingzhong ^b   Zampetaki, Anna ^a   Yin, Xiaoke ^a   Mayr, Manuel ^a   Mori, Kazutoshi ^e   Wang, Wen ^b   Hu, Yanhua ^a   Xu, Qingbo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Inositol; microRNAs; Proteomics; Signal transduction; Vascular remodeling

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BINDING PROTEIN; CALPONIN; CALPONIN H1; GLUCOSE; GLUCOSE RESPONSE PROTEIN 78; INOSITOL; INOSITOL REQUIRING ENZYME 1 ALPHA; MICRORNA; MICRORNA 1274B; MICRORNA 18A; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; THAPSIGARGIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; VASCULOTROPIN; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; MESSENGER RNA; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INJURY; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; FEMORAL ARTERY; GENE DISRUPTION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEOMICS; RNA DEGRADATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; INJURIES; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMORAL ARTERY; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; PLATELET-DERIVED GROWTH FACTOR; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR CROSS-TALK; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR REMODELING; VASCULAR SYSTEM INJURIES;

EID: 84942288066     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATV.0000000000000179     Document Type: Erratum

References (66)

1. Raines EW, Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J. 1993;69(suppl 1):S30-S37.
2. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 2004;15:237-254. doi: 10. 1016/j. cytogfr. 2004. 03. 004.
3. Xu Q. The role of stem cells in atherosclerosis. Arch Mal Coeur Vaiss. 2005;98:672-676.
4. Tang Z, Wang A, Yuan F, Yan Z, Liu B, Chu JS, Helms JA, Li S. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun. 2012;3:875. doi: 10. 1038/ncomms1867.
5. Miyauchi K, Aikawa M, Tani T, Nakahara K, Kawai S, Nagai R, Okada R, Yamaguchi H. Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: possible role of PDGF. Cardiovasc Drugs Ther. 1998;12:251-260.
6. Austin KM, Nguyen N, Javid G, Covic L, Kuliopulos A. Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis. J Biol Chem. 2013;288:23105-23115. doi: 10. 1074/jbc. M113. 467019.
7. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol. 2008;28:1950-1959. doi: 10. 1161/ ATVBAHA. 107. 161224.
8. Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, Fujita T. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest. 1997;100:2824-2832. doi: 10. 1172/JCI119830.
9. Margariti A, Xiao Q, Zampetaki A, Zhang Z, Li H, Martin D, Hu Y, Zeng L, Xu Q. Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells. J Cell Sci. 2009;122(pt 4):460-470. doi: 10. 1242/jcs. 034850.
10. Cattaruzza M, Nogoy N, Wojtowicz A, Hecker M. Zinc finger motif-1 antagonizes PDGF-BB-induced growth and dedifferentiation of vascular smooth muscle cells. FASEB J. 2012;26:4864-4875. doi: 10. 1096/ fj. 12-210302.
11. Li L, Blumenthal DK, Terry CM, He Y, Carlson ML, Cheung AK. PDGFinduced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms. J Cell Biochem. 2011;112:289-298. doi: 10. 1002/jcb. 22924.
12. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, Clowes AW. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res. 2005;96:172-179. doi: 10. 1161/01. RES. 0000154595. 87608. db.
13. Samarakoon R, Dobberfuhl AD, Cooley C, Overstreet JM, Patel S, Goldschmeding R, Meldrum KK, Higgins PJ. Induction of renal fibrotic genes by TGF-?1 requires EGFR activation, p53 and reactive oxygen species. Cell Signal. 2013;25:2198-2209. doi: 10. 1016/j. cellsig. 2013. 07. 007.
14. Xiao Q, Luo Z, Pepe AE, Margariti A, Zeng L, Xu Q. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am J Physiol Cell Physiol. 2009;296:C711-C723. doi: 10. 1152/ ajpcell. 00442. 2008.
15. Nishimura G, Manabe I, Tsushima K, Fujiu K, Oishi Y, Imai Y, Maemura K, Miyagishi M, Higashi Y, Kondoh H, Nagai R. DeltaEF1 mediates TGFbeta signaling in vascular smooth muscle cell differentiation. Dev Cell. 2006;11:93-104. doi: 10. 1016/j. devcel. 2006. 05. 011.
16. Azhar M, Runyan RB, Gard C, Sanford LP, Miller ML, Andringa A, Pawlowski S, Rajan S, Doetschman T. Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Dev Dyn. 2009;238:431-442. doi: 10. 1002/dvdy. 21854.
17. Kingston PA, Sinha S, Appleby CE, David A, Verakis T, Castro MG, Lowenstein PR, Heagerty AM. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factorbeta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty. Circulation. 2003;108:2819-2825. doi: 10. 1161/01. CIR. 0000097068. 49080. A0.
18. Horiuchi A, Nikaido T, Taniguchi S, Fujii S. Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma. J Natl Cancer Inst. 1999;91:790-796.
19. Long X, Slivano OJ, Cowan SL, Georger MA, Lee TH, Miano JM. Smooth muscle calponin: An unconventional CArG-dependent gene that antagonizes neointimal formation. Arterioscler Thromb Vasc Biol. 2011;31:2172-2180. doi: 10. 1161/ATVBAHA. 111. 232785.
20. Horiuchi A, Nikaido T, Ya-Li Z, Ito K, Orii A, Fujii S. Heparin inhibits proliferation of myometrial and leiomyomal smooth muscle cells through the induction of alpha-smooth muscle actin, calponin h1 and p27. Mol Hum Reprod. 1999;5:139-145.
21. Shen X, Ellis RE, Lee K, Liu CY, Yang K, Solomon A, Yoshida H, Morimoto R, Kurnit DM, Mori K, Kaufman RJ. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell. 2001;107:893-903.
22. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, Le QT, Koong AC. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 2004;64:5943-5947. doi: 10. 1158/0008-5472. CAN-04-1606.
23. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001;107:881-891.
24. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519-529. doi: 10. 1038/ nrm2199.
25. Zhou Y, Lee J, Reno CM, Sun C, Park SW, Chung J, Fisher SJ, White MF, Biddinger SB, Ozcan U. Regulation of glucose homeostasis through a xbp-1-foxo1 interaction. Nature medicine. 17:356-365.
26. Zeng L, Xiao Q, Chen M, Margariti A, Martin D, Ivetic A, Xu H, Mason J, Wang W, Cockerill G, Mori K, Li JY, Chien S, Hu Y, Xu Q. Vascular endothelial cell growth-activated XBP1 splicing in endothelial cells is crucial for angiogenesis. Circulation. 2013;127:1712-1722. doi: 10. 1161/ CIRCULATIONAHA. 112. 001337.
27. Liu L, Qi X, Chen Z, Shaw L, Cai J, Smith LH, Grant MB, Boulton ME. Targeting the IRE1?/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization. Am J Pathol. 2013;182:1412-1424. doi: 10. 1016/j. Ajpath. 2012. 12. 020.
28. Silvestre JS. Vascular endothelial growth factor and angiogenesis: the XBP1 games. Circulation. 2013;127:1644-1646. doi: 10. 1161/ CIRCULATIONAHA. 113. 002336.
29. Margariti A, Li H, Chen T, et al. XBP1 mRNA splicing triggers an autophagic response in endothelial cells through BECLIN-1 transcriptional activation. J Biol Chem. 2013;288:859-872. doi: 10. 1074/jbc. M112. 412783.
30. Zeng L, Zampetaki A, Margariti A, Pepe AE, Alam S, Martin D, Xiao Q, Wang W, Jin ZG, Cockerill G, Mori K, Li YS, Hu Y, Chien S, Xu Q. Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow. Proc Natl Acad Sci U S A. 2009;106:8326-8331. doi: 10. 1073/pnas. 0903197106.
31. Liberman M, Johnson RC, Handy DE, Loscalzo J, Leopold JA. Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys Res Commun. 2011;413:436-441. doi: 10. 1016/j. bbrc. 2011. 08. 114.
32. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones. 2007;39:86-93.
33. Marmur JD, Poon M, Rossikhina M, Taubman MB. Induction of PDGFresponsive genes in vascular smooth muscle. Implications for the early response to vessel injury. Circulation. 1992;86(suppl 6):III53-III60.
34. Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, Okada T, Yoshida H, Mori K, Kaufman RJ. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 2002;16:452-466. doi: 10. 1101/ gad. 964702.
35. Back SH, Lee K, Vink E, Kaufman RJ. Cytoplasmic IRE1alpha-mediated XBP1 mRNA splicing in the absence of nuclear processing and endoplasmic reticulum stress. J Biol Chem. 2006;281:18691-18706. doi: 10. 1074/ jbc. M602030200.
36. Lipson KL, Fonseca SG, Ishigaki S, Nguyen LX, Foss E, Bortell R, Rossini AA, Urano F. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab. 2006;4:245-254. doi: 10. 1016/j. cmet. 2006. 07. 007.
37. Oikawa D, Kimata Y. Experimental approaches for elucidation of stresssensing mechanisms of the IRE1 family proteins. Methods Enzymol. 2011;490:195-216. doi: 10. 1016/B978-0-12-385114-7. 00012-X.
38. Lee YK, Brewer JW, Hellman R, Hendershot LM. BiP and immunoglobulin light chain cooperate to control the folding of heavy chain and ensure the fidelity of immunoglobulin assembly. Mol Biol Cell. 1999;10:2209-2219.
39. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, Ross R. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci. 1995;766:416-430.
40. Huang J, Kontos CD. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioscler Thromb Vasc Biol. 2002;22:745-751.
41. Turner NA, Ho S, Warburton P, O'Regan DJ, Porter KE. Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells. J Vasc Surg. 2007;45:1022-1028. doi: 10. 1016/j. jvs. 2007. 01. 061.
42. Sundberg LJ, Galante LM, Bill HM, Mack CP, Taylor JM. An endogenous inhibitor of focal adhesion kinase blocks Rac1/JNK but not Ras/ ERK-dependent signaling in vascular smooth muscle cells. J Biol Chem. 2003;278:29 783-29 791. doi: 10. 1074/jbc. M303771200.
43. Yamaguchi H, Igarashi M, Hirata A, Sugae N, Tsuchiya H, Jimbu Y, Tominaga M, Kato T. Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta. Arterioscler Thromb Vasc Biol. 2004;24:2095-2101. doi: 10. 1161/01. ATV. 0000144009. 35400. 65.
44. Sugenoya Y, Yoshimura A, Yamamura H, Inui K, Morita H, Yamabe H, Ueki N, Ideura T, Takahashi K. Smooth-muscle calponin in mesangial cells: regulation of expression and a role in suppressing glomerulonephritis. J Am Soc Nephrol. 2002;13:322-331.
45. Chen JM, Férec C, Cooper DN. A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants. Hum Genet. 2006;120:301-333. doi: 10. 1007/ s00439-006-0218-x.
46. Meister G. miRNAs get an early start on translational silencing. Cell. 2007;131:25-28. doi: 10. 1016/j. cell. 2007. 09. 021.
47. Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M. Glycoproteomic analysis of the secretome of human endothelial cells. Mol Cell Proteomics. 2013;12:956-978. doi: 10. 1074/mcp. M112. 024018.
48. Wu JW, Hu M, Chai J, Seoane J, Huse M, Li C, Rigotti DJ, Kyin S, Muir TW, Fairman R, Massagué J, Shi Y. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol Cell. 2001;8:1277-1289.
49. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009;78:539-552. doi: 10. 1016/j. bcp. 2009. 04. 029.
50. Tellides G, Pober JS. Inflammatory and immune responses in the arterial media. Circ Res. 2015;116:312-322. doi: 10. 1161/ CIRCRESAHA. 116. 301312.
51. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104:503-516.
52. Mourani PM, Garl PJ, Wenzlau JM, Carpenter TC, Stenmark KR, Weiser-Evans MC. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN. Circulation. 2004;109:1299-1306. doi: 10. 1161/01. CIR. 0000118462. 22970. BE.
53. Shigematsu K, Koyama H, Olson NE, Cho A, Reidy MA. Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury. Arterioscler Thromb Vasc Biol. 2000;20:2373-2378.
54. Holy EW, Jakob P, Eickner T, Camici GG, Beer JH, Akhmedov A, Sternberg K, Schmitz KP, Lüscher TF, Tanner FC. PI3K/p110? inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design. Eur Heart J. 2014;35:808-820. doi: 10. 1093/eurheartj/eht496.
55. Nemenoff RA, Simpson PA, Furgeson SB, Kaplan-Albuquerque N, Crossno J, Garl PJ, Cooper J, Weiser-Evans MC. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cellderived factor-1alpha. Circ Res. 2008;102:1036-1045. doi: 10. 1161/ CIRCRESAHA. 107. 169896.
56. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature. 2005;435:347-353. doi: 10. 1038/nature03587.
57. Samaha FF, Ip HS, Morrisey EE, Seltzer J, Tang Z, Solway J, Parmacek MS. Developmental pattern of expression and genomic organization of the calponin-h1 gene. A contractile smooth muscle cell marker. J Biol Chem. 1996;271:395-403.
58. Miano JM, Olson EN. Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis. J Biol Chem. 1996;271:7095-7103.
59. Montague CR, Hunter MG, Gavrilin MA, Phillips GS, Goldschmidt-Clermont PJ, Marsh CB. Activation of estrogen receptor-alpha reduces aortic smooth muscle differentiation. Circ Res. 2006;99:477-484. doi: 10. 1161/01. RES. 0000238376. 72592. A2.
60. Worth NF, Rolfe BE, Song J, Campbell GR. Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil Cytoskeleton. 2001;49:130-145. doi: 10. 1002/cm. 1027.
61. Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107:823-826.
62. Schopman NC, Heynen S, Haasnoot J, Berkhout B. A miRNA-tRNA mixup: tRNA origin of proposed miRNA. RNA Biol. 2010;7:573-576. doi: 10. 4161/rna. 7. 4. 13141.
63. Della Vittoria Scarpati G, Falcetta F, Carlomagno C, Ubezio P, Marchini S, De Stefano A, Singh VK, D'Incalci M, De Placido S, Pepe S. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1113-1119. doi: 10. 1016/j. ijrobp. 2011. 09. 030.
64. Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res. 2013;351:85-98. doi: 10. 1007/ s00441-012-1514-5.
65. Shinozuka E, Miyashita M, Mizuguchi Y, Akagi I, Kikuchi K, Makino H, Matsutani T, Hagiwara N, Nomura T, Uchida E, Takizawa T. SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells. Biochem Biophys Res Commun. 2013;430:101-106. doi: 10. 1016/j. bbrc. 2012. 11. 005.
66. Guo X, Chen SY. Transforming growth factor-? and smooth muscle differentiation. World J Biol Chem. 2012;3:41-52. doi: 10. 4331/wjbc. v3. i3. 41.